🔴 Ocugen is trading 7.89% down today with no clear company-specific catalyst

Ocugen is trading 7.89% down now at $1.23 after no clear company-specific catalyst was identified for September 9, 2026.

• Ocugen is scheduled to present its modifier gene therapy platform at the Citi 2026 Biopharma Back to School Conference from 3:40–4:15 p.m. ET; the event was announced previously and does not explain the early decline.
• Broader U.S. markets are modestly lower, but the move does not meet the provided threshold for a strong market-wide explanation.
• Volume and activity-level data were unavailable.